INJ jumps 7.46% facing resistance at $3.35: weekly analysis

Traders Union
All News
Crypto
Injective gains 7.46% this week

Highlights

INJ remains under sustained downward pressure, trading well below key moving averages and facing persistent bearish momentum.
Despite a brief 7.46% rebound this week, seller dominance prevails with indicators signaling a likely continuation of the downtrend.
Expected trading range for the next 7 days is $2.70–$3.35, with further downside risk and low probability of near-term upside.

Ongoing bearish momentum as weekly oscillators remain oversold

Technically, weekly momentum stays negative, confirmed by MACD and ADX signaling sustained downward pressure. The Ichimoku Kijun at $6.37 reinforces the distance from any bullish reversal, while the MA-20 at $3.96 sets the closest resistance. Weekly oscillators like RSI and CCI remain in the sell zone, suggesting oversold conditions, and Bull/Bear Power reflects ongoing seller dominance. Key support lies near $2.70, with resistance at $3.35 — volatility stood at 12.77% over the week.

Sideways forecast as downside risk dominates near-term outlook

For the next 7 days, INJ is likely to trade between $2.70 and $3.35, mirroring recent volatility and prevailing downside risk. With all four major weekly indicators (RSI, ADX, MACD, CCI) remaining bearish, the probability of any significant recovery is below 20%. The baseline forecast calls for sideways price action near current levels. For a bullish scenario to unfold, a break above $3.35 is required, while a move below $2.70 would set the stage for a retest of recent lows.

Jainam Mehta, market strategist, believes the 7.46% gain in INJ this week is a modest rebound, but technical signals still point to persistent bearish pressure. With price held below every major moving average and oscillators remaining in the sell zone, he sees little evidence of a trend reversal. The wide gap to dynamic resistance at $3.96 and strong support at $2.70 suggest further sideways movement with downside risk prevailing. "Until INJ reclaims $3.35, I see this as a tactical range market — staying nimble and watching for a potential contrarian setup if oversold conditions intensify."

Earlier, analysts noted that Injective was experiencing persistent selling pressure and lacked decisive bullish momentum, with technicals favoring continued sideways consolidation. The latest weekly data reinforces this outlook, positioning the $3.35 resistance as a key inflection point for any potential shift in near-term direction.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.